X
Please Wait
Applying Filters...
01 NOVO (4)
01 SOLUTION;SUBCUTANEOUS (4)
01 RX (4)
01 OZEMPIC (4)
01 Yes (4)
19
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SEMAGLUTIDE, with a corresponding application number 209637.
Regulatory Information RX
With a dosage strength 2MG/3ML (0.68MG/ML)
Dosage Form Route SOLUTION; SUBCUTANEOUS
Reference Listed Drug Yes
Approved since 2022-10-06
18
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SEMAGLUTIDE, with a corresponding application number 209637.
Regulatory Information RX
With a dosage strength 4MG/3ML (1.34MG/ML)
Dosage Form Route SOLUTION; SUBCUTANEOUS
Reference Listed Drug Yes
Approved since 2019-04-09
17
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SEMAGLUTIDE, with a corresponding application number 209637.
Regulatory Information RX
With a dosage strength 8MG/3ML (2.68MG/ML)
Dosage Form Route SOLUTION; SUBCUTANEOUS
Reference Listed Drug Yes
Approved since 2022-03-28
16
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SEMAGLUTIDE, with a corresponding application number 209637.
Regulatory Information RX
With a dosage strength 2MG/1.5ML (1.34MG/ML)
Dosage Form Route SOLUTION; SUBCUTANEOUS
Reference Listed Drug Yes
Approved since 2017-12-05
Market Place
